{
    "title": "Nektar's opioid painkiller succeeds in key late-stage study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4331294/Nektars-opioid-painkiller-succeeds-key-late-stage-study.html",
    "date": "2017-03-20",
    "keywords": [
        "abuse",
        "drug",
        "brain",
        "doberstein",
        "pain",
        "addiction",
        "placebo",
        "rate",
        "panel",
        "schedule",
        "grovermarch",
        "opioid",
        "relief",
        "euphoria",
        "latestage",
        "studythe",
        "companys",
        "stock",
        "percent",
        "premarket",
        "trading",
        "supply",
        "country",
        "epidemic",
        "overdose",
        "addictionthis",
        "prescription",
        "diversion",
        "paucity",
        "access",
        "treatment",
        "die",
        "disease",
        "control",
        "prevention",
        "cdc",
        "design",
        "science",
        "effect",
        "entry",
        "officer",
        "dr",
        "stephen",
        "saidit",
        "concept",
        "nicotine",
        "cocaine",
        "bloodbrain",
        "dopamine",
        "formulation",
        "liability",
        "study",
        "standpoint",
        "standard",
        "therapy",
        "wave",
        "toll",
        "healthcare",
        "systemlast",
        "week",
        "fda",
        "longacting",
        "painkiller",
        "opana",
        "er",
        "plc",
        "variation",
        "oxymorphine",
        "productsunder",
        "substance",
        "act",
        "risk",
        "harm",
        "come",
        "category",
        "iii",
        "classificationthe",
        "company",
        "food",
        "administration",
        "partner",
        "reporting",
        "grover",
        "bengaluru",
        "editing",
        "anil",
        "dsilva"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}